UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

MHC typing in variant Creutzfeldt-Jakob disease

Pepys, M.B. and Bybee, A. and Booth, D.R. and Bishop, M.T. and Will, R.G. and Little, A.-M and Prokupek, B. and Madrigal, J.A. (2003) MHC typing in variant Creutzfeldt-Jakob disease. The Lancet , 361 (9356) pp. 487-489. 10.1016/S0140-6736(03)12455-5.

Full text not available from this repository.

Abstract

Summary: Identification of factors that cause susceptibility to, and clinical expression of, variant Creutzfeldt-Jakob disease (vCJD) is essential for future management of the disease. We established MHC genotypes of 76 individuals with vCJD and 131 controls, and analysed MHC phenotypes in relation to age of onset of vCJD and its duration from presentation to death. There were no significant differences between vCJD and control populations in frequencies of any MHC types, nor were there associations between MHC type and age of onset or duration of vCJD disease. Our results do not support the idea of an association between MHC types and either susceptibility to, or expression of, vCJD.

Type:Article
Title:MHC typing in variant Creutzfeldt-Jakob disease
DOI:10.1016/S0140-6736(03)12455-5
Publisher version:http://dx.doi.org/10.1016/S0140-6736(03)12455-5
Language:English
UCL classification:UCL > School of Life and Medical Sciences > Faculty of Medical Sciences > Wolfson Institute and Cancer Institute Administration > Cancer Institute > Research Department of Haematology
UCL > School of Life and Medical Sciences > Faculty of Medical Sciences > Wolfson Institute and Cancer Institute Administration > Cancer Institute
UCL > School of Life and Medical Sciences > Faculty of Medical Sciences > Medicine (Division of) > Inflammation

Archive Staff Only: edit this record